eRF Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of eRF Antibodies for research in protein synthesis and translation termination. eRF Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eRF, or eukaryotic release factor, plays a crucial role in the termination of protein synthesis by recognizing stop codons on mRNA and promoting the release of newly synthesized polypeptide chains. Understanding eRF function is essential for elucidating the mechanisms of gene expression and the regulation of protein synthesis, which are fundamental processes in cellular biology. Research on eRF has significant implications for various diseases where protein synthesis dysregulation can lead to pathological conditions. Investigating eRF mechanisms provides insights into cellular homeostasis and potential therapeutic interventions. Exploring eRF's role in translation termination advances knowledge of fundamental biological processes. Santa Cruz Biotechnology monoclonal antibodies for eRF research support scientists in making meaningful discoveries that contribute to understanding protein synthesis regulation and disease mechanisms.